These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 12707070

  • 1. Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma.
    Fliessbach K, Urbach H, Helmstaedter C, Pels H, Glasmacher A, Kraus JA, Klockgether T, Schmidt-Wolf I, Schlegel U.
    Arch Neurol; 2003 Apr; 60(4):563-8. PubMed ID: 12707070
    [Abstract] [Full Text] [Related]

  • 2. Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study.
    Fliessbach K, Helmstaedter C, Urbach H, Althaus A, Pels H, Linnebank M, Juergens A, Glasmacher A, Schmidt-Wolf IG, Klockgether T, Schlegel U.
    Neurology; 2005 Apr 12; 64(7):1184-8. PubMed ID: 15824344
    [Abstract] [Full Text] [Related]

  • 3. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.
    Iuvone L, Mariotti P, Colosimo C, Guzzetta F, Ruggiero A, Riccardi R.
    Cancer; 2002 Dec 15; 95(12):2562-70. PubMed ID: 12467071
    [Abstract] [Full Text] [Related]

  • 4. Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma.
    Juergens A, Pels H, Rogowski S, Fliessbach K, Glasmacher A, Engert A, Reiser M, Diehl V, Vogt-Schaden M, Egerer G, Schackert G, Reichmann H, Kroschinsky F, Bode U, Herrlinger U, Linnebank M, Deckert M, Fimmers R, Schmidt-Wolf IG, Schlegel U.
    Ann Neurol; 2010 Feb 15; 67(2):182-9. PubMed ID: 20225195
    [Abstract] [Full Text] [Related]

  • 5. Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
    Hoang-Xuan K, Taillandier L, Chinot O, Soubeyran P, Bogdhan U, Hildebrand J, Frenay M, De Beule N, Delattre JY, Baron B, European Organization for Research and Treatment of Cancer Brain Tumor Group.
    J Clin Oncol; 2003 Jul 15; 21(14):2726-31. PubMed ID: 12860951
    [Abstract] [Full Text] [Related]

  • 6. Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma.
    McAllister LD, Doolittle ND, Guastadisegni PE, Kraemer DF, Lacy CA, Crossen JR, Neuwelt EA.
    Neurosurgery; 2000 Jan 15; 46(1):51-60; discussion 60-1. PubMed ID: 10626935
    [Abstract] [Full Text] [Related]

  • 7. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
    Dahlborg SA, Petrillo A, Crossen JR, Roman-Goldstein S, Doolittle ND, Fuller KH, Neuwelt EA.
    Cancer J Sci Am; 1998 Jan 15; 4(2):110-24. PubMed ID: 9532413
    [Abstract] [Full Text] [Related]

  • 8. Non-AIDS primary CNS lymphoma: first example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy.
    Dahlborg SA, Henner WD, Crossen JR, Tableman CM, Petrillo A, Braziel R, Neuwelt EA.
    Cancer J Sci Am; 1996 Jan 15; 2(3):166-74. PubMed ID: 9166517
    [Abstract] [Full Text] [Related]

  • 9. NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report.
    Herrlinger U, Küker W, Uhl M, Blaicher HP, Karnath HO, Kanz L, Bamberg M, Weller M, Neuro-Oncology Working Group of the German Society.
    Ann Neurol; 2005 Jun 15; 57(6):843-7. PubMed ID: 15929034
    [Abstract] [Full Text] [Related]

  • 10. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
    Dabaja BS, McLaughlin P, Ha CS, Pro B, Meyers CA, Seabrooke LF, Wilder RB, Kyritsis AP, Preti HA, Yung WK, Levin V, Cabanillas F, Cox JD.
    Cancer; 2003 Sep 01; 98(5):1021-8. PubMed ID: 12942571
    [Abstract] [Full Text] [Related]

  • 11. Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy.
    Pels H, Schmidt-Wolf IG, Glasmacher A, Schulz H, Engert A, Diehl V, Zellner A, Schackert G, Reichmann H, Kroschinsky F, Vogt-Schaden M, Egerer G, Bode U, Schaller C, Deckert M, Fimmers R, Helmstaedter C, Atasoy A, Klockgether T, Schlegel U.
    J Clin Oncol; 2003 Dec 15; 21(24):4489-95. PubMed ID: 14597744
    [Abstract] [Full Text] [Related]

  • 12. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
    Pöttgen C, Stuschke M, Stüben G, Schmitz A, Schwechheimer K, Wacker HH, Rauhut F, Kleuker S, Wilhelm H, Grehl S, Fehlings T.
    Strahlenther Onkol; 2003 Sep 15; 179(9):626-32. PubMed ID: 14628129
    [Abstract] [Full Text] [Related]

  • 13. Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma.
    Gavrilovic IT, Hormigo A, Yahalom J, DeAngelis LM, Abrey LE.
    J Clin Oncol; 2006 Oct 01; 24(28):4570-4. PubMed ID: 17008697
    [Abstract] [Full Text] [Related]

  • 14. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
    Yi JQ, Lin TY, He YJ, Huang HQ, Xia ZJ, Xia YF, Xu RH, Guo Y, Guan ZZ.
    Ai Zheng; 2006 Apr 01; 25(4):476-80. PubMed ID: 16613684
    [Abstract] [Full Text] [Related]

  • 15. Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.
    Abrey LE, Moskowitz CH, Mason WP, Crump M, Stewart D, Forsyth P, Paleologos N, Correa DD, Anderson ND, Caron D, Zelenetz A, Nimer SD, DeAngelis LM.
    J Clin Oncol; 2003 Nov 15; 21(22):4151-6. PubMed ID: 14615443
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Multi-modality therapy leads to longer survival in primary central nervous system lymphoma patients.
    Singhal D, Witham TF, Germanwala A, Flickinger JC, Schiff D, Kondziolka D.
    Can J Neurol Sci; 2002 May 15; 29(2):147-53. PubMed ID: 12035835
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Preliminary results of combined chemotherapy and radiotherapy for non-AIDS primary central nervous system lymphoma. Trans-Tasman Radiation Oncology Group (TROG).
    O'Brien PC, Roos DE, Liew KH, Trotter GE, Barton MB, Walker QJ, Poulsen MG, Olver IN.
    Med J Aust; 1996 Oct 21; 165(8):424-7. PubMed ID: 8913243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.